Financial News
Latest News about SNY
Recent news which mentions SNY
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
April 17, 2024
From Benzinga
From Benzinga
From Benzinga
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
April 12, 2024
From Benzinga
From InvestorPlace
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
April 10, 2024
From Benzinga
Why Is Auddia (AUUD) Stock Up 192% Today?
April 08, 2024
From InvestorPlace
From InvestorPlace
From InvestorPlace
In Heart Burn Drug Zantac's Litigation Saga, Sanofi Nears Settlement in Major Lawsuit Cluster
April 04, 2024
From Benzinga
From Benzinga
Krispy Kreme-McDonald's Deal Spikes Insulin Stock Interest: 'We're About To Cash In On The Aftermath'
March 26, 2024
From Benzinga
To the Moon and Beyond: 7 Stocks With Cosmic Potential
March 14, 2024
From InvestorPlace
From InvestorPlace
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
March 04, 2024
From InvestorPlace
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
February 28, 2024
From Benzinga
3 Cash Cow Dividend Stocks for Outsized Income & Upside
February 27, 2024
From InvestorPlace
Move Over Magnificent 7, Say Hello to the GRANOLAS
February 22, 2024
From InvestorPlace
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
February 16, 2024
From Motley Fool
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
From InvestorPlace
The 3 Biotech Stocks That Could Make Your February Unforgettable
February 15, 2024
From InvestorPlace
What's Going On Eli Lilly Stock Thursday?
February 08, 2024
From Benzinga
CytoReason's AI-Driven Disease Model Platform Trusted By 5 Top 10 Pharma Companies Harnesses Big Data To Speed Drug Discovery And Development
February 05, 2024
From Benzinga
From Benzinga
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 01, 2024
From Benzinga
French Pharma Giant Sanofi's Q4 Earnings Hit By Aubagio Generic Competition, Helped By Flagship Eczema And Newly Launched Hemophilia Drugs
February 01, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
